☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
first biologic
GSK's Benlysta (belimumab- IV) Receives EC's Approvals as the First Biologic to Treat Lupus in Children
October 30, 2019
GSK's Nucala (mepolizumab) Receives the US FDA's Approval as First Biologic for Severe Eosinophilic Asthma in Children Aged 6-11yr...
September 13, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.